eFFECTOR Therapeutics (EFTRW) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends EFTRW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying eFFECTOR Therapeutics stock or one of its competitors? The main competitors of eFFECTOR Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. eFFECTOR Therapeutics vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics eFFECTOR Therapeutics (NASDAQ:EFTRW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, community ranking, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment. Is EFTRW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets eFFECTOR TherapeuticsN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has preferable valuation and earnings, EFTRW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeFFECTOR TherapeuticsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the MarketBeat Community believe in EFTRW or ATNFW? eFFECTOR Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformeFFECTOR TherapeuticsN/AN/A180 Life SciencesN/AN/A Does the media prefer EFTRW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than eFFECTOR Therapeutics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for eFFECTOR Therapeutics. 180 Life Sciences' average media sentiment score of 1.87 beat eFFECTOR Therapeutics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment eFFECTOR Therapeutics Neutral 180 Life Sciences Very Positive Summary180 Life Sciences beats eFFECTOR Therapeutics on 2 of the 2 factors compared between the two stocks. Remove Ads Get eFFECTOR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EFTRW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFTRW vs. The Competition Export to ExcelMetriceFFECTOR TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$114.78M$5.67B$8.01BDividend YieldN/A3.69%4.89%4.03%P/E RatioN/A3.2223.8318.90Price / SalesN/A4,308.08380.44118.46Price / CashN/A13.0138.0534.62Price / BookN/A35.886.834.18Net IncomeN/A-$87.82M$3.19B$246.59M eFFECTOR Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFTRWeFFECTOR TherapeuticsN/AN/AN/AN/A$0.00N/A0.0010ATNFW180 Life SciencesN/A$0.01-36.9%N/A+21.4%$0.00N/A0.007Positive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$12.00-5.7%N/AN/A$0.00N/A0.0018Analyst ForecastAnalyst RevisionNews CoverageAEHAWAesther Healthcare AcquisitionN/A$0.03+17.0%N/A-85.4%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.08-12.0%N/A+73.4%$0.00$40,633.000.0040Positive NewsGap DownALVOWAlvotechN/A$2.05-6.8%N/A-64.5%$0.00$391.87M0.004Positive NewsGap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03-2.9%N/AN/A$0.00N/A0.004BFRIWBiofronteraN/A$0.08+36.4%N/A+45.0%$0.00$35.36M0.0070Positive NewsBTMDWbioteN/A$0.08-22.7%N/AN/A$0.00$193.06M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.10-2.8%N/A-93.6%$0.00N/A0.008Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AARD Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ACABW Alternatives BFRIW Alternatives BTMDW Alternatives BCTXW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EFTRW) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersFormer CIA to Trump – Will you Shut down this secret lab?Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… ...Paradigm Press | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMarch 18th: Gold SHOCK? On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredMusk’s real agenda in Washington… In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | SponsoredDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EFTRW Stock Alerts